Historical record - last NADAC effective date: 6/19/2024
Product Information
PROAIR DIGIHALER 90 MCG INHALR is a brand product labeled by Teva Respiratory, LLC, priced at $86.2606 per EA under NDC 59310011720. Its NADAC has been published 208 times since Jun 23, 2021.
FDA first approved this application on Mar 31, 2015.
The High Outlier badge above means this manufacturer's average price in the albuterol sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
90 ug/1
Manufacturer
Teva Respiratory, LLCNDC
59310011720
Classification
Brand
Dosage Form
INHALANT
Route
RESPIRATORY (INHALATION)
Effective Date
6/19/2024
Active Ingredients
ALBUTEROL SULFATEApproval Type
New Drug (NDA)
FDA Application
NDA205636FDA Approved
3/31/2015
On Market Since
10/4/2019
Pharmacological Classes
Price Statistics
The NADAC for PROAIR DIGIHALER 90 MCG INHALR has been published 208 times since Jun 23, 2021, and over the history we have for it it has declined 39.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $86.2606 per EA |
|---|---|
| All-time high | $148.8413 (Apr 13, 2022) |
| All-time low | $86.2606 (Jun 19, 2024) |
| Median price | $86.4837 |
| Average price | $108.6441 |
| Largest weekly change | -41.5% (Dec 21, 2022) |
| Weeks tracked | 208 |
| Tracking since | Jun 23, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-0.1%
5Y
-39.2%
All
-39.2%
Last surveyed Jun 11, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the albuterol sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Respiratory, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
albuterol sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta2-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROAIR DIGIHALER 90 MCG INHALR?
The current National Average Drug Acquisition Cost (NADAC) for PROAIR DIGIHALER 90 MCG INHALR, manufactured by Teva Respiratory, LLC, is $86.2606 per EA (NDC 59310011720), effective Jun 11, 2025.
How has the price of PROAIR DIGIHALER 90 MCG INHALR changed over time?
Over the history we have for it, the NADAC for PROAIR DIGIHALER 90 MCG INHALR has declined 39.2%. It has been tracked across 208 weekly CMS publications since Jun 23, 2021.
What are the highest and lowest recorded NADAC prices for PROAIR DIGIHALER 90 MCG INHALR?
Since Jun 23, 2021, the NADAC for PROAIR DIGIHALER 90 MCG INHALR has ranged from a low of $86.2606 (Jun 19, 2024) to a high of $148.8413 (Apr 13, 2022), with a median of $86.4837 per EA.
Are there cheaper alternatives to PROAIR DIGIHALER 90 MCG INHALR?
No other NADAC-published product currently shares the active ingredient and strength of PROAIR DIGIHALER 90 MCG INHALR in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PROAIR DIGIHALER 90 MCG INHALR?
PROAIR DIGIHALER 90 MCG INHALR (NDC 59310011720) is labeled by Teva Respiratory, LLC, and CMS classifies it as a brand product.